354 related articles for article (PubMed ID: 25423143)
1. Breast cancer detection with short-interval follow-up compared with return to annual screening in patients with benign stereotactic or US-guided breast biopsy results.
Johnson JM; Johnson AK; O'Meara ES; Miglioretti DL; Geller BM; Hotaling EN; Herschorn SD
Radiology; 2015 Apr; 275(1):54-60. PubMed ID: 25423143
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up.
Kerlikowske K; Smith-Bindman R; Abraham LA; Lehman CD; Yankaskas BC; Ballard-Barbash R; Barlow WE; Voeks JH; Geller BM; Carney PA; Sickles EA
Radiology; 2005 Mar; 234(3):684-92. PubMed ID: 15734926
[TBL] [Abstract][Full Text] [Related]
3. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
[TBL] [Abstract][Full Text] [Related]
4. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
[TBL] [Abstract][Full Text] [Related]
5. Utility of 6-month follow-up imaging after a concordant benign breast biopsy result.
Salkowski LR; Fowler AM; Burnside ES; Sisney GA
Radiology; 2011 Feb; 258(2):380-7. PubMed ID: 21079199
[TBL] [Abstract][Full Text] [Related]
6. What Happens after a Diagnosis of High-Risk Breast Lesion at Stereotactic Vacuum-assisted Biopsy? An Observational Study of Postdiagnosis Management and Imaging Adherence.
Gao Y; Albert M; Young Lin LL; Lewin AA; Babb JS; Heller SL; Moy L
Radiology; 2018 May; 287(2):423-431. PubMed ID: 29378151
[TBL] [Abstract][Full Text] [Related]
7. National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.
Sprague BL; Arao RF; Miglioretti DL; Henderson LM; Buist DS; Onega T; Rauscher GH; Lee JM; Tosteson AN; Kerlikowske K; Lehman CD;
Radiology; 2017 Apr; 283(1):59-69. PubMed ID: 28244803
[TBL] [Abstract][Full Text] [Related]
8. Benign breast lesions: minimally invasive vacuum-assisted biopsy with 11-gauge needles patient acceptance and effect on follow-up imaging findings.
Huber S; Wagner M; Medl M; Czembirek H
Radiology; 2003 Mar; 226(3):783-90. PubMed ID: 12616021
[TBL] [Abstract][Full Text] [Related]
9. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy.
Sydnor MK; Wilson JD; Hijaz TA; Massey HD; Shaw de Paredes ES
Radiology; 2007 Jan; 242(1):58-62. PubMed ID: 17090707
[TBL] [Abstract][Full Text] [Related]
10. Small (< 2.0-cm) breast cancers: mammographic and US findings at US-guided cryoablation--initial experience.
Roubidoux MA; Sabel MS; Bailey JE; Kleer CG; Klein KA; Helvie MA
Radiology; 2004 Dec; 233(3):857-67. PubMed ID: 15567802
[TBL] [Abstract][Full Text] [Related]
11. Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight Study.
Brem RF; Tabár L; Duffy SW; Inciardi MF; Guingrich JA; Hashimoto BE; Lander MR; Lapidus RL; Peterson MK; Rapelyea JA; Roux S; Schilling KJ; Shah BA; Torrente J; Wynn RT; Miller DP
Radiology; 2015 Mar; 274(3):663-73. PubMed ID: 25329763
[TBL] [Abstract][Full Text] [Related]
12. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
Duijm LE; Groenewoud JH; Roumen RM; de Koning HJ; Plaisier ML; Fracheboud J
Breast Cancer Res Treat; 2007 Nov; 106(1):113-9. PubMed ID: 17219049
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Breast Biopsy With Benign Results Does Not Negatively Affect Future Screening Adherence.
Lewin AA; Gao Y; Lin Young LL; Albert ML; Babb JS; Toth HK; Moy L; Heller SL
J Am Coll Radiol; 2018 Apr; 15(4):622-629. PubMed ID: 29433804
[TBL] [Abstract][Full Text] [Related]
14. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer detection rate: designing imaging trials to demonstrate improvements.
Jiang Y; Miglioretti DL; Metz CE; Schmidt RA
Radiology; 2007 May; 243(2):360-7. PubMed ID: 17456866
[TBL] [Abstract][Full Text] [Related]
16. Tailored breast cancer screening program with microdose mammography, US, and MR Imaging: short-term results of a pilot study in 40-49-year-old women.
Venturini E; Losio C; Panizza P; Rodighiero MG; Fedele I; Tacchini S; Schiani E; Ravelli S; Cristel G; Panzeri MM; De Cobelli F; Del Maschio A
Radiology; 2013 Aug; 268(2):347-55. PubMed ID: 23579052
[TBL] [Abstract][Full Text] [Related]
17. The value of 6-month interval imaging after benign radiologic-pathologic concordant minimally invasive breast biopsy.
Manjoros DT; Collett AE; Alberty-Oller JJ; Frazier TG; Barrio AV
Ann Surg Oncol; 2013 Oct; 20(10):3163-8. PubMed ID: 23975288
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
[TBL] [Abstract][Full Text] [Related]
19. Comparison of screening mammography in the United States and the United kingdom.
Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
[TBL] [Abstract][Full Text] [Related]
20. US follow-up protocol in concordant benign result after US-guided 14-gauge core needle breast biopsy.
Youk JH; Jung I; Kim EK; Kim MJ; Son EJ; Moon HJ; Kwak JY
Breast Cancer Res Treat; 2012 Apr; 132(3):1089-97. PubMed ID: 22218886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
